5'-methyl-4-pentyl-2'-(prop-1-en-2-yl)-1',2',3',6'-tetrahydro-[1,1'-biphenyl]-2,6-diol | 913477-37-9

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 异戊烯醇脂质
• 英文名称: 5'-methyl-4-pentyl-2'-(prop-1-en-2-yl)-1',2',3',6'-tetrahydro-[1,1'-biphenyl]-2,6-diol
• 英文别名: 2-(6-isopropenyl-3-methyl-3-cyclohexene-1-yl)-5-pentyl-1,3-benzenediol；2-(6-isopropenyl-3-methyl-3-cyclohexen-1-yl)-5-pentyl-1,3-benzenediol；2-(6-isopropenyl-3-methylcyclohex-3-enyl)-5-pentylbenzene-1,3-diol；2-(3-Methyl-6-prop-1-en-2-ylcyclohex-3-en-1-yl)-5-pentylbenzene-1,3-diol
• CAS: 913477-37-9
• 化学式: C₂₁H₃₀O₂
• 分子量: 314.468
• InChiKey: ZTGXAWYVTLUPDT-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  6.3
• 重原子数：
  23
• 可旋转键数：
  6
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.52
• 拓扑面积：
  40.5
• 氢给体数：
  2
• 氢受体数：
  2

文献信息

• Pharmaceutical composition and method of manufacturing
  申请人：Speier Gary J.

  公开号：US10238705B2

  公开（公告）日：2019-03-26

  The present invention provides for methods of obtaining an extract of Cannabis plant material as well as subsequent processing of the extract to provide a concentrate of Cannabis. The present invention also provides for pharmaceutical dosage forms (e.g., oral thin films and transdermal patches) that include the concentrate (or extract) of Cannabis, as well as methods of medical treatment that include administering the pharmaceutical dosage forms.

  本发明提供了获得大麻植物材料提取物的方法，以及对提取物进行后续加工以提 供大麻浓缩物的方法。本发明还提供了包括大麻浓缩物（或提取物）的药物剂型（如口服薄膜和透皮贴剂），以及包括施用药物剂型的医疗方法。
• USE OF TOPICAL FORMULATIONS OF CANNABINOIDS IN THE TREATMENT OF EPIDERMOLYSIS BULLOSA AND RELATED CONNECTIVE TISSUE DISORDERS
  申请人：Inmed Pharmaceuticals Inc.

  公开号：EP3452036A1

  公开（公告）日：2019-03-13
• METABOLIC ENGINEERING OF E. COLI FOR THE BIOSYNTHESIS OF CANNABINOID PRODUCTS
  申请人：Inmed Pharmaceuticals Inc.

  公开号：EP3679146A1

  公开（公告）日：2020-07-15
• TOPICAL FORMULATIONS OF CANNABINOIDS AND USE THEREOF IN THE TREATMENT OF PAIN
  申请人：Inmed Pharmaceuticals Inc.

  公开号：EP3684353A1

  公开（公告）日：2020-07-29
• TOPICAL CANNABINOID FORMULATIONS AND INSTILLATES, KITS, AND METHODS FOR TREATING INTEGUMENTARY WOUNDS, AND USES THEREOF
  申请人：Vinsan Therapeutics Inc.

  公开号：EP3771313A1

  公开（公告）日：2021-02-03